Early, Brief Course of Methylprednisolone May Improve COVID-19 Outcomes Early, Brief Course of Methylprednisolone May Improve COVID-19 Outcomes

In patients hospitalized for moderate or severe COVID-19, an early, short course of methylprednisolone appears to reduce the risks of death and the need for intensive care and mechanical ventilation, a new quasi-experimental study suggests.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news